GTS Securities’s Boston Scientific BSX Stock Holding History

GTS Securities’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$437K	Sell	6,962 -6,968	-50%	-$557K	0.02%	834
2025 Q4	$1.33M	Buy	13,930 +4,682	+51%	+$459K	0.05%	331
2025 Q3	$903K	Buy	+9,248	New	+$958K	0.03%	464
2025 Q2	–	Sell	-8,574	Closed	-$865K	–	1258
2025 Q1	$865K	Buy	8,574 +90	+1%	+$9.06K	0.04%	449
2024 Q4	$758K	Sell	8,484 -73,354	-90%	-$6.46M	0.04%	452
2024 Q3	$6.86M	Buy	81,838 +48,538	+146%	+$3.83M	0.01%	700
2024 Q2	$2.56M	Sell	33,300 -2,816	-8%	-$206K	0.01%	1309
2024 Q1	$2.47M	Sell	36,116 -211	-0.6%	-$13.6K	﹤0.01%	1342
2023 Q4	$2.1M	Buy	36,327 +27,848	+328%	+$1.49M	﹤0.01%	1619
2023 Q3	$448K	Buy	+8,479	New	+$445K	﹤0.01%	2730

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GTS Securities's BSX Position: Q1 2026 in Review

GTS Securities reduced its Boston Scientific (BSX) stake by 50% in Q1 2026, selling an estimated $557K and leaving 6,962 shares worth $437K. The position accounts for 0.02% of the portfolio, ranked #834.

GTS Securities first reported a position in BSX in Q3 2023 and has held it in 10 quarters since. The position peaked at $6.86M in Q3 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

GTS Securities held 6,962 shares of Boston Scientific worth $437K as of Q1 2026.
GTS Securities sold 6,968 Boston Scientific shares in Q1 2026, an estimated $557K.
Boston Scientific made up 0.02% of GTS Securities's portfolio in Q1 2026, its #834 holding.
GTS Securities first reported a position in Boston Scientific in Q3 2023 and has held it in 10 quarters since.
GTS Securities's Boston Scientific position peaked at $6.86M in Q3 2024.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.